| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | For oral administration |
|
Still deciding? Get samples of US$ 0/Box
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Indications
For the symptomatic relief of mouth and throat infections.
Dosage and Administration
Dosage:
Use the lowest dose for the shortest duration necessary to relieve symptoms.
Adults,Children over 6 years old:One chewable tablet every 2-3 hours up to a maximum of 12 chewable tabletes in 24 hours.
Elderly:There is no need for dosage reduction in the elderly.
Children under 6 years old:Not suitable for children under 6 years
Usage:
Oral, swallow after chewing.
Contraindications:
Hypersensitivity to any of the ingredients.
Precautions & Warning:
1.Not to be given to children under 6 years
2.If symptoms persist, have not improved, or have worsened after 3 days, consult a doctor or health care professional.
3.One chewable tablet contains no more than 19.36 micrograms of gluten.This medicine contains only very low levels of gluten (from wheat starch). It is regarded as 'gluten-free' and is very unlikely to cause problems if you have coeliac disease.
If you have wheat allergy (different from coeliac disease) you should not take this medicine.
4.This medicine contains 3 mg propylene glycol in each Lozenge.
5.This medicine contains fragrance with Citral, Citronellol, d-Limonene, Geraniol and Linalool. Citral, Citronellol, d-Limonene,
Geraniol and Linalool may cause allergic reactions.
6.This medicine contains glucose (0.97g per lozenge) and sucrose (1.44g per lozenge). This should be taken into account in patients with diabetes mellitus. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltose insufficiency should not take this medicine.
7.This medicine contains sulphites - Sulphur dioxide (E220) which may rarely cause severe hypersensitivity reactions and bronchospasm.
8.This medicine contains colouring agents (Ponceau 4R (E124) and Sunset Yellow (E110)), which may cause allergic reactions.
Adverse Reactions:
The list of the following adverse effects relates to those experienced with 2,4-dichlorobenzyl alcohol and amylmetacresol at OTC doses, in short term use.
Adverse events which have been associated with 2,4-dichlorobenzyl alcohol and amylmetacresol are given below, tabulated by system organ class and frequency. Frequencies are defined as: Very common (≥ 1/10); Common (≥ 1/100 and <1/10); Uncommon (≥ 1/1000 and <1/100); Rare (≥ 1/10,000 and <1/1000); Very rare (<1/10,000); Not known (cannot be estimated from the available data). Within each frequency grouping, adverse events are presented in order of decreasing seriousness.
|
System Organ Class |
Frequency |
Adverse Events |
|
Immune System Disorders |
Not known |
Hypersensitivityab1 |
|
Gastrointestinal Disorders |
Not known |
Glossodyniaab, oral discomfortab |
1Hypersensitivity reactions may include rash, urticaria and angioedema, which may include swelling of the face, neck, throat or tongue that could affect breathing.
Drug interactions:
No clinically significant interactions are known.
Storage instructions:
Do not store above 25° C.
){kind=link}